Smoking ban and indoor air quality in restaurants in Mumbai, India
Lalit J Raute1, Prakash C Gupta, Mangesh S Pednekar
1Healis Sekhsaria Institute for Public Health, Navi Mumbai, India.
Background:
Second-hand smoke contains several toxic chemicals that are known to pollute the air and harm people's health. In India, smoking in public places has been prohibited since October 2008 as a way to reduce second-hand smoke (SHS) exposure. The purpose of the present study was to assess the implementation of smoke-free policies and its impact on indoor air quality by measuring the PM(2.5) levels in bars and restaurants, restaurants, country liquor bars, hookah restaurants and pubs in Mumbai.
Materials And Methods:
Air quality measurements at 50 venues were conducted by using a "SIDEPAK(™) AM510 Personal Aerosol Monitor" during April to May 2009. Average concentration of PM(2.5) (μg/m(3)) particles was calculated separately for each venue.
Results:
Smoking was observed in 36% of the surveyed venues during an hour of data collection. The PM(2.5) levels ranged from 16.97 to 1101.76 μg/m(3). The average level of PM(2.5) among non-smoking venues was 97.19 μg/m(3) and among smoking venues was 363.04 μg/m(3).
Conclusion:
Considerable scope for improvement in implementation of smoke-free policies exists. The PM(2.5) levels were exceedingly high in venues where smoking was observed.
More Related Videos
07:12Façade-Level Monitoring of CO2 Variability under Urban Heat Island Conditions using Low-Cost Sensor Data Loggers
Published on: December 12, 2025
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Other Pulmonary Disorders
